-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Suzhou, October 4, 2021/PRNewswire/ - Development Pharmaceutical Co.
The study (NCT05009732) is a randomized, double-blind, placebo-controlled, global multi-center phase III pivotal clinical trial, which aims to explore the effectiveness and safety of Prokrutamide in the treatment of hospitalized patients with new coronary disease
Dr.
About Kaixing Pharmaceutical
Founded in 2009, Kai Kuang Pharmaceutical focuses on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs, and is committed to becoming a leader in the research, development and commercialization of innovative therapies
Source: Kaifeng Pharmaceutical